Literature DB >> 2878004

Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.

K U Bühring, A Garbe.   

Abstract

High-performance liquid chromatographic methods using fluorimetric detection have been developed for the determination in plasma and urine of bisoprolol, atenolol, metoprolol and propranolol. Bisoprolol, metoprolol and propranolol were extracted at alkaline pH with dichloromethane, atenolol with n-butanol-dichloromethane (25:75). After evaporation of the organic solvent the compounds were chromatographed on silica gel Si-60 columns (normal phase) using aqueous ammonium phosphate buffer (pH 4) containing 3-7% acetonitrile as eluent (method 1). Alternatively, the compounds were acetylated prior to chromatography on reversed-phase columns (RP-8), using acetonitrile-water mixtures as eluents (method 2). The detection limit was 1-2 ng/ml in plasma and 10 ng/ml in urine for bisoprolol and metoprolol with either method. For atenolol the detection limit was 5 ng/ml in plasma or 50 ng/ml in urine (method 1), for propranolol 1 ng/ml in plasma (method 2).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878004     DOI: 10.1016/s0378-4347(00)83519-7

Source DB:  PubMed          Journal:  J Chromatogr


  10 in total

1.  A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.

Authors:  M S Dixon; P Thomas; D J Sheridan
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.

Authors:  R Lewis; D Maclean; C Ioannides; A Johnston; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 3.  Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.

Authors:  S G Lancaster; E M Sorkin
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

4.  Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol.

Authors:  P H Joubert; C P Venter; A Wellstein
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Population pharmacokinetic analysis of bisoprolol.

Authors:  J Grevel; P Thomas; B Whiting
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

6.  Population pharmacokinetics of bisoprolol in patients with chronic heart failure.

Authors:  Valentina N Nikolic; Tatjana Jevtovic-Stoimenov; Radmila Velickovic-Radovanović; Stevan Ilic; Marina Deljanin-Ilic; Dragan Marinkovic; Svetlana Apostolović; Dragana Stanojevic; Slavoljub Zivanovic; Nikola Stefanovic; Srdjan Pesic; Dejana Ruzic Zecevic; Jasmina R Milovanovic; Slobodan M Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2012-10-24       Impact factor: 2.953

7.  Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol.

Authors:  P A Soons; C Grib; D D Breimer; W Kirch
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

8.  Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.

Authors:  W Kirch; I Rose; H G Demers; G Leopold; J Pabst; E E Ohnhaus
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

9.  Effects of small doses of bisoprolol on blood pressure and lipoprotein concentrations in hypertensive patients.

Authors:  H Lithell; L Weiner; B Vessby; M L Nordström
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets.

Authors:  D N Vora; A A Kadav
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.